Early stage development of the glycine-1 re-uptake inhibitor SCH 900435: central nervous system effects compared with placebo in healthy men

Author(s):
Liem-Moolenaar, M.; Peeters, P.; Kamerling, I.M.C.; Hogg, C.; Holder, G.; Kleijn, H.J.; Spaans, E.; Haes, J.U. de; Kam, M.L. de; Franson, K.L.; Cohen, A.F.; Gerven, J.M.A. van (0000-0002-1444-7415)
Published
2013
Publication type
Article / Letter to editor
antipsychoticcentral nervous systemglycine-1 re-\uptake inhibitorhealthy volunteersschizophrenia
Date issued
2013-06-30
Language
English
Is part of
British Journal of Clinical Pharmacology (2013), Vol. 75, no. 6, p. 1455-1467
hdl
1887/106495
doi
10.1111/bcp.12015